Pantoprazole Actavis (Pantoprazole Sodium)

Pantoprazole, the active ingredient in Pantoprazole Actavis, is a proton pump inhibitor presented as a unknown strength/unknown form for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and ulcers in adults.

GNH USA supplies Pantoprazole Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole Actavis is a proton pump inhibitor that acts on gastric acid secretion pathways. It is prescribed for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and promotes healing of the oesophageal lining. - Erosive oesophagitis: heals erosions in the oesophagus caused by acid exposure. - Peptic ulcer disease: supports ulcer healing and reduces recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with this rare endocrine disorder.

Pantoprazole may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools occurring during early treatment. - Nausea: feeling of queasiness without vomiting. - Abdominal pain: discomfort or cramping in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhoea. - Severe allergic reaction: rash, itching, swelling, dizziness, or trouble breathing. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat, or seizures. - Liver enzyme elevation: increased ALT or AST indicating hepatic stress. - Fracture risk: potential reduction in bone mineral density with long‑term use.

When prescribing Pantoprazole, clinicians should consider several safety aspects: - Renal impairment: adjust use in patients with severe kidney dysfunction. - Hepatic impairment: use cautiously in moderate to severe liver disease. - Long‑term therapy: monitor bone health and magnesium levels during extended treatment. - Drug interactions: review concomitant medications for potential PK/PD effects. - Pregnancy and lactation: evaluate risk‑benefit ratio before use. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazole can affect the pharmacokinetics of several co‑administered drugs. Awareness of interaction severity helps guide monitoring.

Major Interactions (Avoid): - Antifungal agents (e.g., ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - Atorvastatin: increased plasma concentrations increasing risk of myopathy. - Clopidogrel: diminished antiplatelet effect, potentially reducing cardioprotect 

Moderate 

---

------

---  

---  

---  

---  

---  

---  t

---  

---  

---  

---  

--- 

--- 

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

--- 

---

---

---

--- 

---

---

---

---

---